Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1324

1.

Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program).

Hess PL, Sheng S, Matsouaka R, DeVore AD, Heidenreich PA, Yancy CW, Bhatt DL, Allen LA, Peterson PN, Ho PM, Lewis WR, Hernandez AF, Fonarow GC, Piccini JP.

Am J Cardiol. 2019 Dec 30. pii: S0002-9149(19)31494-8. doi: 10.1016/j.amjcard.2019.12.025. [Epub ahead of print]

PMID:
31980141
2.

Urgent Balloon Aortic Valvuloplasty or Urgent TAVR in Patients With Severe Aortic Stenosis: A Propensity-Matched Analysis.

Bandyopadhyay D, Chakraborty S, Amgai B, Patel N, Hajra A, Ghosh RK, Kolte D, Fonarow GC, Ramee SR, Lavie CJ, Abbott JD.

JACC Cardiovasc Interv. 2020 Jan 27;13(2):274-275. doi: 10.1016/j.jcin.2019.09.020. No abstract available.

PMID:
31973805
3.

Heart Failure With Mid-range Ejection Fraction.

Srivastava PK, Hsu JJ, Ziaeian B, Fonarow GC.

Curr Heart Fail Rep. 2020 Feb;17(1):1-8. doi: 10.1007/s11897-019-00451-0. Review.

PMID:
31925667
4.

Measuring and Improving the Quality of Heart Failure Care Globally.

Smith SC Jr, Fonarow GC, Zhao D.

JAMA Netw Open. 2020 Jan 3;3(1):e1918642. doi: 10.1001/jamanetworkopen.2019.18642. No abstract available.

5.

Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries.

Pandey A, Keshvani N, Khera R, Lu D, Vaduganathan M, Joynt Maddox KE, Das SR, Kumbhani DJ, Goyal A, Girotra S, Chan P, Fonarow GC, Matsouaka R, Wang TY, de Lemos JA.

JAMA Cardiol. 2020 Jan 8. doi: 10.1001/jamacardio.2019.4845. [Epub ahead of print]

PMID:
31913411
6.

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.

Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Hylek EM, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Heart. 2020 Mar;106(5):358-364. doi: 10.1136/heartjnl-2019-315792. Epub 2020 Jan 7.

PMID:
31911503
7.

Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.

Shah S, Liang L, Kosinski A, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Feng W, Peterson ED, Xian Y.

Circ Cardiovasc Qual Outcomes. 2020 Jan;13(1):e006031. doi: 10.1161/CIRCOUTCOMES.119.006031. Epub 2020 Jan 6.

PMID:
31903770
8.

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

Butler J, Packer M, Greene SJ, Fiuzat M, Anker SD, Anstrom KJ, Carson PE, Cooper LB, Fonarow GC, Hernandez AF, Januzzi JL Jr, Jessup M, Kalyani RR, Kaul S, Kosiborod M, Lindenfeld J, McGuire DK, Sabatine MS, Solomon SD, Teerlink JR, Vaduganathan M, Yancy CW, Stockbridge N, O'Connor CM.

Circulation. 2019 Dec 17;140(25):2108-2118. doi: 10.1161/CIRCULATIONAHA.119.042155. Epub 2019 Dec 16.

PMID:
31841369
9.

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.

Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP.

Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007612. doi: 10.1161/CIRCEP.119.007612. Epub 2019 Dec 13.

PMID:
31830822
10.

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure.

Kelly JP, DeVore AD, Wu J, Hammill BG, Sharma A, Cooper LB, Felker GM, Piccini JP, Allen LA, Heidenreich PA, Peterson ED, Yancy CW, Fonarow GC, Hernandez AF.

J Am Heart Assoc. 2019 Dec 17;8(24):e011560. doi: 10.1161/JAHA.118.011560. Epub 2019 Dec 10.

11.

Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.

Pokorney SD, Holmes DN, Shrader P, Thomas L, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Naccarelli GV, Freeman JV, Singer DE, Washam JB, Peterson ED, Piccini JP, Reiffel JA.

Am Heart J. 2020 Feb;220:145-154. doi: 10.1016/j.ahj.2019.09.017. Epub 2019 Oct 23.

PMID:
31812756
12.

Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.

Bhatt AS, Vaduganathan M, Patel RB, Fonarow GC, Subacius HP, Konstam MA, Zannad F, Butler J, Greene SJ.

Eur J Heart Fail. 2020 Jan;22(1):164-167. doi: 10.1002/ejhf.1651. Epub 2019 Dec 3. No abstract available.

PMID:
31797490
13.

Reply: What Is Important for Digoxin Treatment in Patients With Heart Failure.

Fonarow GC, Masson R, Ahmed A.

J Am Coll Cardiol. 2019 Dec 3;74(22):2827-2828. doi: 10.1016/j.jacc.2019.09.047. No abstract available.

PMID:
31779804
14.

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF.

DeVore AD, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Lewis EF, Butler J, Piña IL, Heidenreich PA, Allen LA, Yancy CW, Cooper LB, Felker GM, Kaltenbach LA, McRae AT, Lanfear DE, Harrison RW, Kociol RD, Disch M, Ariely D, Miller JM, Granger CB, Hernandez AF.

Am Heart J. 2020 Feb;220:41-50. doi: 10.1016/j.ahj.2019.09.012. Epub 2019 Oct 23.

PMID:
31770656
15.

Assessment of Heart Failure Patients' Interest in Mobile Health Apps for Self-Care: Survey Study.

Sohn A, Speier W, Lan E, Aoki K, Fonarow G, Ong M, Arnold C.

JMIR Cardio. 2019 Oct 29;3(2):e14332. doi: 10.2196/14332.

16.

Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes.

Bandyopadhyay D, Chakraborty S, Amgai B, Patel N, Hajra A, Heise L, Sud K, Ghosh RK, Herzog E, Aronow WS, Fonarow GC, Lavie CJ.

Int J Cardiol. 2020 Feb 15;301:21-28. doi: 10.1016/j.ijcard.2019.11.096. Epub 2019 Nov 12.

PMID:
31757650
17.

Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure.

Sharma A, Wu J, Ezekowitz JA, Felker GM, Udell JA, Heidenreich PA, Fonarow GC, Mahaffey KW, Hernandez AF, DeVore AD.

ESC Heart Fail. 2019 Nov 20. doi: 10.1002/ehf2.12528. [Epub ahead of print]

18.

Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure.

Sumarsono A, Vaduganathan M, Ajufo E, Navar AM, Fonarow GC, Das SR, Pandey A.

JAMA Cardiol. 2019 Nov 18. doi: 10.1001/jamacardio.2019.4982. [Epub ahead of print]

PMID:
31738371
19.

Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial.

Yancy CW, Fonarow GC, Hernandez AF.

JAMA Cardiol. 2019 Nov 18. doi: 10.1001/jamacardio.2019.5019. [Epub ahead of print] No abstract available.

PMID:
31738365
20.

Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.

Samsky MD, Lin L, Greene SJ, Lippmann SJ, Peterson PN, Heidenreich PA, Laskey WK, Yancy CW, Greiner MA, Hardy NC, Kavati A, Park S, Mentz RJ, Fonarow GC, O'Brien EC.

JAMA Cardiol. 2019 Nov 17. doi: 10.1001/jamacardio.2019.4987. [Epub ahead of print]

PMID:
31734700
21.

Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.

Vaduganathan M, Fonarow GC, Greene SJ, DeVore AD, Albert NM, Duffy CI, Hill CL, Spertus JA, Thomas LE, Butler J.

J Am Coll Cardiol. 2019 Dec 24;74(25):3176-3178. doi: 10.1016/j.jacc.2019.10.020. Epub 2019 Nov 11. No abstract available.

PMID:
31727426
22.

Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.

Fanaroff AC, Peterson ED, Kaltenbach LA, Cannon CP, Choudhry NK, Henry TD, Anstrom KJ, Cohen DJ, Fonseca E, Khan ND, Fonarow GC, Wang TY.

JAMA Cardiol. 2019 Nov 13. doi: 10.1001/jamacardio.2019.4408. [Epub ahead of print]

PMID:
31721978
23.

Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.

Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP.

Am Heart J. 2020 Jan;219:21-30. doi: 10.1016/j.ahj.2019.10.008. Epub 2019 Nov 8.

PMID:
31710841
24.

Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF).

Giblin EM, Adams KF Jr, Hill L, Fonarow GC, Williams FB, Sharma PP, Albert NM, Butler J, DeVore AD, Duffy CI, Hernandez AF, McCague K, Spertus JA, Thomas L, Patterson JH.

Am J Cardiol. 2019 Dec 15;124(12):1900-1906. doi: 10.1016/j.amjcard.2019.09.020. Epub 2019 Sep 26.

PMID:
31679641
25.

Chest Pain Center Accreditation Is Associated With Improved In-Hospital Outcomes of Acute Myocardial Infarction Patients in China: Findings From the CCC-ACS Project.

Fan F, Li Y, Zhang Y, Li J, Liu J, Hao Y, Smith SC Jr, Fonarow GC, Taubert KA, Ge J, Zhao D, Huo Y; CCC‐ACS Investigators.

J Am Heart Assoc. 2019 Nov 5;8(21):e013384. doi: 10.1161/JAHA.119.013384. Epub 2019 Oct 19. Erratum in: J Am Heart Assoc. 2019 Dec 17;8(24):e002317.

26.

Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure.

Ghosh RK, Ghosh GC, Gupta M, Bandyopadhyay D, Akhtar T, Deedwania P, Lavie CJ, Fonarow GC, Aneja A.

Am J Cardiol. 2019 Dec 1;124(11):1790-1796. doi: 10.1016/j.amjcard.2019.08.038. Epub 2019 Sep 10. Review.

PMID:
31627834
27.

PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure.

Sayeed S, Fudim M, Devore AD, Xu H, Matsouaka RA, Heidenreich PA, Yancy CW, Fonarow GC, Hernandez AF.

J Card Fail. 2019 Dec;25(12):1009-1011. doi: 10.1016/j.cardfail.2019.10.003. Epub 2019 Oct 15. No abstract available.

PMID:
31626949
28.

Association of Hospital Racial Composition and Payer Mix With Mortality in Acute Coronary Syndrome.

Srivastava PK, Fonarow GC, Bahiru E, Ziaeian B.

J Am Heart Assoc. 2019 Nov 5;8(21):e012831. doi: 10.1161/JAHA.119.012831. Epub 2019 Oct 18.

29.

Heart Failure Self-care Associated With Brain Injury in Executive Control Regions.

Choi S, Roy B, Kumar R, Fonarow GC, Woo MA.

J Cardiovasc Nurs. 2019 Nov/Dec;34(6):433-439. doi: 10.1097/JCN.0000000000000611.

PMID:
31609280
30.

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.

Greene SJ, DeVore AD, Sheng S, Fonarow GC, Butler J, Califf RM, Hernandez AF, Matsouaka RA, Samman Tahhan A, Thomas KL, Vaduganathan M, Yancy CW, Peterson ED, O'Connor CM, Mentz RJ.

JACC Heart Fail. 2019 Nov;7(11):980-992. doi: 10.1016/j.jchf.2019.07.011. Epub 2019 Oct 9.

PMID:
31606362
31.

The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper.

Psotka MA, Fonarow GC, Allen LA, Joynt Maddox KE, Fiuzat M, Heidenreich P, Hernandez AF, Konstam MA, Yancy CW, O'Connor CM.

JACC Heart Fail. 2020 Jan;8(1):1-11. doi: 10.1016/j.jchf.2019.07.012. Epub 2019 Oct 9. Review.

PMID:
31606360
32.

Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017.

Sumarsono A, Everett BM, McGuire DK, Fonarow GC, Butler J, Pandey A, Vaduganathan M.

JAMA Intern Med. 2019 Sep 30. doi: 10.1001/jamainternmed.2019.3884. [Epub ahead of print] No abstract available.

PMID:
31566649
33.

Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.

Ball S, Ghosh RK, Wongsaengsak S, Bandyopadhyay D, Ghosh GC, Aronow WS, Fonarow GC, Lenihan DJ, Bhatt DL.

J Am Coll Cardiol. 2019 Oct 1;74(13):1714-1727. doi: 10.1016/j.jacc.2019.07.079. Review. Erratum in: J Am Coll Cardiol. 2019 Nov 26;74(21):2711-2712.

PMID:
31558256
34.

Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?

Rymer JA, Chen AY, Thomas L, Fonarow GC, Peterson ED, Wang TY.

J Am Heart Assoc. 2019 Oct;8(19):e012059. doi: 10.1161/JAHA.119.012059. Epub 2019 Sep 20.

35.

Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction.

Khariton Y, Fonarow GC, Arnold SV, Hellkamp A, Nassif ME, Sharma PP, Butler J, Thomas L, Duffy CI, DeVore AD, Albert NM, Patterson JH, Williams FB, McCague K, Spertus JA.

JACC Heart Fail. 2019 Nov;7(11):933-941. doi: 10.1016/j.jchf.2019.05.016. Epub 2019 Sep 11.

PMID:
31521679
36.

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score.

Segar MW, Vaduganathan M, Patel KV, McGuire DK, Butler J, Fonarow GC, Basit M, Kannan V, Grodin JL, Everett B, Willett D, Berry J, Pandey A.

Diabetes Care. 2019 Dec;42(12):2298-2306. doi: 10.2337/dc19-0587. Epub 2019 Sep 13.

PMID:
31519694
37.

Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction.

Greene SJ, Fonarow GC, Butler J.

J Am Coll Cardiol. 2019 Sep 10;74(10):1426-1427. doi: 10.1016/j.jacc.2019.06.061. No abstract available.

PMID:
31488284
38.

The Medicare Shared Savings Program and Outcomes for Ischemic Stroke Patients: a Retrospective Cohort Study.

Kaufman BG, O'Brien EC, Stearns SC, Matsouaka R, Holmes GM, Weinberger M, Song PH, Schwamm LH, Smith EE, Fonarow GC, Xian Y.

J Gen Intern Med. 2019 Dec;34(12):2740-2748. doi: 10.1007/s11606-019-05283-1. Epub 2019 Aug 26.

PMID:
31452032
39.

Intravenous Tissue Plasminogen Activator in Stroke Mimics.

Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005609. doi: 10.1161/CIRCOUTCOMES.119.005609. Epub 2019 Aug 15.

PMID:
31412730
40.

The changing landscape of aortic valve replacement in the USA.

Gupta T, Kolte D, Khera S, Goel K, Villablanca PA, Kalra A, Abbott JD, Elmariah S, Fonarow GC, Rihal CS, Garcia MJ, Weisz G, Bhatt DL; Collaborators.

EuroIntervention. 2019 Dec 6;15(11):e968-e974. doi: 10.4244/EIJ-D-19-00381.

41.

Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.

Lam PH, Packer M, Fonarow GC, Faselis C, Allman RM, Morgan CJ, Singh SN, Pitt B, Ahmed A.

Am J Med. 2020 Feb;133(2):e25-e31. doi: 10.1016/j.amjmed.2019.06.053. Epub 2019 Aug 8.

PMID:
31401165
42.

Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Malik A, Masson R, Singh S, Wu WC, Packer M, Pitt B, Waagstein F, Morgan CJ, Allman RM, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2019 Aug 6;74(5):617-627. doi: 10.1016/j.jacc.2019.05.064.

PMID:
31370952
43.

Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.

Echouffo-Tcheugui JB, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC.

Eur J Heart Fail. 2019 Sep;21(9):1093-1102. doi: 10.1002/ejhf.1552. Epub 2019 Jul 29.

PMID:
31359595
44.

Regional Differences in Secondary Prevention Therapy-Geography Should Not Be Destiny.

Navar AM, Fonarow GC.

JAMA Cardiol. 2019 Jul 24. doi: 10.1001/jamacardio.2019.2548. [Epub ahead of print] No abstract available.

PMID:
31339523
45.

Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.

Malik A, Gill GS, Lodhi FK, Tummala LS, Singh SN, Morgan CJ, Allman RM, Fonarow GC, Ahmed A.

Am J Med. 2020 Jan;133(1):84-94. doi: 10.1016/j.amjmed.2019.06.040. Epub 2019 Jul 20.

PMID:
31336093
46.

Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.

Xian Y, Xu H, O'Brien EC, Shah S, Thomas L, Pencina MJ, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Hannah D, Maisch L, Lytle BL, Peterson ED, Hernandez AF.

JAMA Neurol. 2019 Jul 22. doi: 10.1001/jamaneurol.2019.2099. [Epub ahead of print]

PMID:
31329212
47.

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.

Inohara T, Liang L, Kosinski AS, Smith EE, Schwamm LH, Hernandez AF, Bhatt DL, Fonarow GC, Peterson ED, Xian Y.

J Am Heart Assoc. 2019 Aug 6;8(15):e012450. doi: 10.1161/JAHA.119.012450. Epub 2019 Jul 20.

48.

Hospital distance, socioeconomic status, and timely treatment of ischemic stroke.

Ader J, Wu J, Fonarow GC, Smith EE, Shah S, Xian Y, Bhatt DL, Schwamm LH, Reeves MJ, Matsouaka RA, Sheth KN.

Neurology. 2019 Aug 20;93(8):e747-e757. doi: 10.1212/WNL.0000000000007963. Epub 2019 Jul 18.

PMID:
31320472
49.

Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.

Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, Xian Y, Holmes DN, Peterson ED, Yavagal D, Smith EE.

JAMA. 2019 Jul 16;322(3):252-263. doi: 10.1001/jama.2019.8286.

50.

Impediments to Implementing Guideline-Directed Medical Therapies.

Fonarow GC, Navar AM, Yancy CW.

JAMA Cardiol. 2019 Jul 10. doi: 10.1001/jamacardio.2019.2276. [Epub ahead of print] No abstract available.

PMID:
31290930

Supplemental Content

Loading ...
Support Center